Summary
Boston Scientific Corporation (BSX) filed a Form 8-K on July 20, 2007, to report its financial results for the second quarter ended June 30, 2007. The report primarily consists of a press release (Exhibit 99.1) detailing these financial outcomes. Investors should note that this filing itself does not contain detailed financial figures but rather serves as a notification of the release of this information. The press release, which is furnished as an exhibit, would contain the specific operational and financial condition updates relevant to the quarter.
Key Highlights
- 1Boston Scientific Corporation (BSX) issued a press release on July 20, 2007, announcing its second-quarter financial results.
- 2The 8-K filing serves as a notification vehicle for the release of these quarterly financial results.
- 3The press release, furnished as Exhibit 99.1, contains the detailed financial and operational information for the quarter ended June 30, 2007.
- 4This filing is made pursuant to Item 2.02 (Results of Operations and Financial Condition) of Form 8-K.
- 5The information provided in the 8-K and its exhibit is not deemed 'filed' for Section 18 of the Exchange Act, meaning it does not carry the same liability as formally filed documents under that section.
Frequently Asked Questions
The primary purpose of this Form 8-K filing is to officially announce and provide Boston Scientific Corporation's financial results for the second quarter ended June 30, 2007, by furnishing a press release containing these details.
The detailed financial results are contained within the press release issued by Boston Scientific Corporation on July 20, 2007, which is attached as Exhibit 99.1 to this Form 8-K filing.
No, the Form 8-K itself, as filed on July 20, 2007, does not list specific financial figures. It only indicates that a press release containing these results has been issued and is provided as an exhibit.
This statement means that the information furnished in this 8-K report and its exhibits is not subject to the same strict liability provisions under Section 18 of the Securities Exchange Act of 1934, which governs liability for false or misleading statements in filed reports. However, it is still considered important public disclosure.